Global Medical Director, Riliprubart

Sanofi•Cambridge, MA

12d

About The Position

In order to pursue Sanofi’s purpose of “Chasing the miracles of science to improve people’s lives”, Specialty Care Medical Affairs have a vision to be the leaders in patient and scientific knowledge and insights to improve clinical care. We do this by generating and curating the most critical patient and scientific evidence and by being highly credible partners shaping scientific exchange and engagement. We serve as key strategic partners for commercial, regulatory, R&D, market access and external affairs to develop and launch first in class and best in class therapeutic solutions that address highest unmet needs.

Requirements

Deep expertise in Neurology & Neuromuscular Diseases, preferred.
Minimum of 4 years’ experience in relevant Medical Affairs
Demonstrated industry experience working in strategic roles from medical affairs or clinical development related areas including scientific KOL engagement, evidence generation and scientific communication at Global and Key Market level, preferred.
Broad drug development experience with robust knowledge of regulatory, market access and reimbursement.
Demonstrated experience in managing clinical trials in a pharmaceutical environment is strongly desired.
Demonstrated specialty care product launch experience at a country level, strongly preferred.
Significant line and matrix management experience, including strong transversal collaboration with key functions such as Research, Clinical Development, Commercial, Health Economics, Value and Access and Product Management functions.
Strategic thinking: ability to disrupt status quo with innovation while remaining pragmatic and focused on priorities.
Result orientation: ability to develop and execute optimal strategy meeting corporate objectives, while creating pragmatic solutions.
Comfortable with ambiguity and ability to adapt with agility, take calculated risks and anticipate potential issues.
People Leadership: ability to engage and leverage everyone’s strengths while being highly self-aware.
Set high standards and expectations, communicates proactively, collaborative and approachable and ability to provide meaningful feedback, coaching and support.
Effective stakeholder management, and role model for collaboration and teamwork
Highest ethical, regulatory and scientific standards
Doctorate in relevant scientific discipline or Pharmacy – Medical Degree preferred
Fluent in English.

Responsibilities

Co-develop, plan and lead the execution of the medical strategy for riliprubart across the product value chain.
Co-create the IEGP strategy with Medical Evidence Generation Lead and other evidence generation-related functions: Clinical Study Unit (CSU), Real World Evidence (RWE), Health Economics Outcomes Research (HEVA), Medical Operations and Effectiveness (MO&E) and country teams.
Lead the execution of assigned medical affairs studies.
Provide input in design, monitoring, analysis, and communication of the assigned studies.
Serve as a global medical point of contact for such studies for internal and external stakeholders.
Oversee insight generation plan and input to the assigned assets overall medical strategy.
Provide strategic input to Scientific Communications team to plan and execute evidence dissemination and medical education plans.
Build trust with Global external stakeholders to advance their understanding of the therapeutic area and evolve the treatment landscapes for CIDP and riliprubart.
Oversee the design of medical programs/initiatives to drive the therapeutic value of riliprubart and address unmet medical needs (i.e., MAPs, PSP, Diagnostic support programs, CSRs, etc)
Oversee the adherence to allocated budgets, plan and execute activities aligned with strategy and smart execution principles to assure prioritization and cross-functional alignment.
Accountable for medical affairs review and scientific integrity of internal and external medical materials.